Algernon Pharmaceuticals Acquires NoBrainer Imaging to Expand into Alzheimer’s Diagnostics and Treatment
Algernon Pharmaceuticals Inc. has acquired NoBrainer Imaging Centers, Inc. to expand its presence in the neurological healthcare sector, particularly in the Alzheimer’s disease diagnostic and treatment market.
3 minutes to read